Yes, startups tend to be corporations. And really, the model is "sell the startup to American corporations, who then milk Americans". Pfizer bought BioNTech's

Yes, startups tend to be corporations. And really, the model is "sell the startup to American corporations, who then milk Americans". Pfizer bought BioNTech's (Turkish/German) mRNA tech, for example. Insulin's price skyrocketed, despite being a hundred years old. It didn't get harder to make, distribute, sell. They just wanted more. Or Shkreli's purchase of Daraprim (https://www.bbc.com/news/business-34917918 https://www.bbc.com/news/business-34917918), a ~70 year old drug. They hiked the price from $13.50/pill to $750/pill. Did it get 55x harder to make suddenly? Of course not. It still costs $1/pill to make.